Rising Regulatory Costs Will Erode Margins Despite US Wins
AN
AnalystLowTarget
Not Invested
Consensus Narrative from 10 Analysts
Published
22 Jun 25
Updated
09 Aug 25
AnalystLowTarget's Fair Value
US$16.00
49.7% overvalued intrinsic discount09 Aug
US$23.95
1Y
9.6%7D
5.3%